Market Share of NTRK Fusion Gene Positive Advanced Solid Tumor Industry
The global NTRK Fusion Gene Positive Advanced Solid Tumor market is competitive and consists of a few major players. Companies like Bayer AG, Cephalon, Inc., Empire Genomics, LLC., Exelixis, Inc, F. Hoffmann-La Roche Ltd, NeoGenomics Laboratories, Inc., OncoDNA, among others, hold the substantial market share in the market.
NTRK Fusion Gene Positive Advanced Solid Tumor Market Leaders
-
Bayer AG
-
Empire Genomics, LLC
-
F. Hoffmann-La Roche Ltd.
-
NeoGenomics Laboratories, Inc.
-
OncoDNA
*Disclaimer: Major Players sorted in no particular order